Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda

Παρόμοια τεκμήρια

• Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
  από: Mpendo J, κ.ά.
  Έκδοση: (2012-09-01)
• Sexual behavior among volunteers enrolled in a Phase I HIV vaccine trial: experience of Projet San Francisco in Kigali, Rwanda
  από: Mukamuyango J, κ.ά.
  Έκδοση: (2012-09-01)
• Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
  από: Juliet Mpendo, κ.ά.
  Έκδοση: (2020-01-01)
• A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.
  από: Juliet Mpendo, κ.ά.
  Έκδοση: (2015-01-01)
• Community health worker promotions increase uptake of long-acting reversible contraception in Rwanda
  από: Amelia Mazzei, κ.ά.
  Έκδοση: (2019-06-01)